Projects

Sepsis surveillance in patients with head-and-neck cancer undergoing chemo-radiation

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2023

Project Lead

Ajay Babu

Authors

Ajay Babu, Hadrian Noel Alexander F, Sandeep Muzumder, Nirmala Srikantia, Avinash H Udayashanka

Project Status

completed

Project Type

Retrosective Cohort Study